About the role
Serif Biomedicines is a privately held, early-stage biotechnology company developing a novel approach to gene therapy that can address currently untreatable diseases.
Many pages were opened from here in the last minute, so the full ad isn’t loaded. It’s on the company’s site. Read it there ↗